Urapidil, the active substance in Uragelan®, is a blood pressure-lowering drug from the group of alpha-adrenoceptor antagonists. On the one hand, it causes a decrease in vascular resistance (via a blockade of alpha receptors). This dilates the blood vessels and lowers the blood pressure. On the other hand, it also prevents the counter-reaction (increase in heart rate) of the autonomic nervous system. The heart rate therefore remains largely constant.
Uragelan® Gebrauchsinformation 30 mg, 60 mg, Stand 06.2020
Uragelan® Gebrauchsinformation 90 mg, Stand 07.2020
| Strength | Pack size | Dosage form | Appearance |
| 30 mg | 30, 60 | Hard capsules |
|
| 60 mg | 30, 60 | Hard capsules |
|
| 90 mg | 30, 60 | Hard capsules |
|
